Home / Lifestyle / Health & Fitness / Article / WHO warns about counterfeit diabetes drugs in circulation worldwide

WHO warns about counterfeit diabetes drugs in circulation worldwide

The drug concerns Ozempic, a medicine containing the active ingredient semaglutide, which is also approved in the EU for the treatment of Type 2 diabetes. The counterfeit version looks identical to the real medicine

  • WhatsAppBookmarkBookmark
Listen to this article :
Image for representational purpose only. Photo Courtesy: istock

Image for representational purpose only. Photo Courtesy: istock

Counterfeit diabetes drugs have been in circulation since 2022, a problem affecting all regions of the world, the World Health Organization warned in a statement.

The health authority on Thursday referred specifically to findings in Britain, the US and Brazil since October 2023.

Read Next Story
Healthy BMI, no smoking effective ways to reduce risk of kidney cancer: Experts

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All